Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge J Castillo

Showing results (161-170 of 343) with videos related to

Pageof 35
Sort By:
Leukemia Research|September 7, 2014
Erythrocyte membrane fatty acids in multiple myeloma patientsArtur Jurczyszyn, Jacek Czepiel, Joanna Gdula-Argasińska, et al.
American Journal of Hematology|July 3, 2024
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and managementLuis Malpica, Mario L Marques-Piubelli, Brady E Beltran, et al.
Hematological Oncology|June 23, 2017
Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphomaBrady E Beltran, Pilar Quiñones, Domingo Morales, et al.
The Oncologist|February 20, 2010
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Leukemia & Lymphoma|October 6, 2010
Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Blood Advances|July 17, 2025
Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysisAlberto Guijosa, Andres Ramirez-Gamero, Shayna Sarosiek, et al.
Leukemia Research|February 9, 2021
Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphomaDenisse Castro, Brady Beltrán, María Del Pilar Quiñones, et al.
Ejhaem|September 2, 2022
A pilot study on dasatinib in patients with Waldenström macroglobulinemia progressing on ibrutinibJorge J Castillo, Shayna Sarosiek, Catherine A Flynn, et al.
Leukemia & Lymphoma|May 3, 2023
The prognostic role of red cell distribution width on all-cause and cause-specific outcomes in peripheral T-cell lymphoma: a retrospective cohort studyDenisse Castro, Bryan Valcarcel, Thanya Runciman, et al.
BMC Cancer|July 31, 2016
The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patientsJorge J Castillo, Ilya G Glezerman, Susan H Boklage, et al.
Pageof 35

Showing results (161-170 of 343) with videos related to

Sort By:
Pageof 35
Leukemia Research|September 7, 2014
Erythrocyte membrane fatty acids in multiple myeloma patientsArtur Jurczyszyn, Jacek Czepiel, Joanna Gdula-Argasińska, et al.
American Journal of Hematology|July 3, 2024
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and managementLuis Malpica, Mario L Marques-Piubelli, Brady E Beltran, et al.
Hematological Oncology|June 23, 2017
Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphomaBrady E Beltran, Pilar Quiñones, Domingo Morales, et al.
The Oncologist|February 20, 2010
Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Leukemia & Lymphoma|October 6, 2010
Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphomaJorge J Castillo, Eric S Winer, Dariusz Stachurski, et al.
Blood Advances|July 17, 2025
Ibrutinib plus rituximab versus ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysisAlberto Guijosa, Andres Ramirez-Gamero, Shayna Sarosiek, et al.
Leukemia Research|February 9, 2021
Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphomaDenisse Castro, Brady Beltrán, María Del Pilar Quiñones, et al.
Ejhaem|September 2, 2022
A pilot study on dasatinib in patients with Waldenström macroglobulinemia progressing on ibrutinibJorge J Castillo, Shayna Sarosiek, Catherine A Flynn, et al.
Leukemia & Lymphoma|May 3, 2023
The prognostic role of red cell distribution width on all-cause and cause-specific outcomes in peripheral T-cell lymphoma: a retrospective cohort studyDenisse Castro, Bryan Valcarcel, Thanya Runciman, et al.
BMC Cancer|July 31, 2016
The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patientsJorge J Castillo, Ilya G Glezerman, Susan H Boklage, et al.
Pageof 35